| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 176 | 2018 |
| Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users L Baandrup, BH Ebdrup, JØ Rasmussen, J Lindschou, C Gluud, ... Cochrane Database of Systematic Reviews, 2018 | 149 | 2018 |
| Chronic post-traumatic headache–a clinical analysis in relation to the international headache classification 2nd edition L Baandrup, R Jensen Cephalalgia 25 (2), 132-138, 2005 | 146 | 2005 |
| Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study L Baandrup, C Gasse, VD Jensen, BY Glenthoj, M Nordentoft, H Lublin, ... The Journal of clinical psychiatry 70 (2), 1111, 2009 | 143 | 2009 |
| Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) A Egerton, BV Broberg, N Van Haren, K Merritt, GJ Barker, DJ Lythgoe, ... Molecular psychiatry 23 (11), 2145-2155, 2018 | 129 | 2018 |
| Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate P Cayé‐Thomasen, L Baandrup, GK Jacobsen, J Thomsen, ... The Laryngoscope 113 (12), 2129-2134, 2003 | 89 | 2003 |
| Low-dose aspirin use and the risk of ovarian cancer in Denmark L Baandrup, SK Kjær, JH Olsen, C Dehlendorff, S Friis Annals of Oncology 26 (4), 787-792, 2015 | 75 | 2015 |
| Polypharmacy in schizophrenia L Baandrup Basic & clinical pharmacology & toxicology 126 (3), 183-192, 2020 | 66 | 2020 |
| Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis L Baandrup, J Sørensen, H Lublin, M Nordentoft, B Glenthoj The European Journal of Health Economics 13, 355-363, 2012 | 50 | 2012 |
| Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized … L Baandrup, B Fagerlund, B Glenthoj European archives of psychiatry and clinical neuroscience 267 (2), 163-171, 2017 | 48 | 2017 |
| Statin use and risk for ovarian cancer: a Danish nationwide case–control study L Baandrup, C Dehlendorff, S Friis, JH Olsen, SK Kjaer British journal of cancer 112 (1), 157-161, 2015 | 46 | 2015 |
| Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use L Baandrup, BY Glenthøj, PJ Jennum Psychiatry research 240, 163-169, 2016 | 44 | 2016 |
| Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study P Jennum, L Baandrup, R Ibsen, J Kjellberg European neuropsychopharmacology 25 (11), 1906-1913, 2015 | 44 | 2015 |
| Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial L Baandrup, J Lindschou, P Winkel, C Gluud, BY Glenthoj The World Journal of Biological Psychiatry 17 (7), 514-524, 2016 | 42 | 2016 |
| A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder L Baandrup, PJ Jennum Neuropsychiatric disease and treatment, 2271-2277, 2015 | 42 | 2015 |
| Treatment of adult patients with schizophrenia and complex mental health needs–A national clinical guideline L Baandrup, J Østrup Rasmussen, L Klokker, S Austin, T Bjørnshave, ... Nordic journal of psychiatry 70 (3), 231-240, 2016 | 38 | 2016 |
| Persistent negative symptoms in recent-onset psychosis: relationship to treatment response and psychosocial functioning P Bucci, A Mucci, IW van Rossum, C Aiello, C Arango, L Baandrup, ... European Neuropsychopharmacology 34, 76-86, 2020 | 37 | 2020 |
| Increased all-cause mortality with psychotropic medication in Parkinson's disease and controls: a national register-based study R Frandsen, L Baandrup, J Kjellberg, R Ibsen, P Jennum Parkinsonism & related disorders 20 (11), 1124-1128, 2014 | 33 | 2014 |
| Evaluation of a multifaceted intervention to limit excessive antipsychotic co‐prescribing in schizophrenia out‐patients L Baandrup, P Allerup, H Lublin, M Nordentoft, L Peacock, B Glenthoj Acta Psychiatrica Scandinavica 122 (5), 367-374, 2010 | 31 | 2010 |
| Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia O Köhler, HT Horsdal, L Baandrup, O Mors, C Gasse Clinical epidemiology, 323-332, 2016 | 29 | 2016 |
